Navigation Links
Eppendorf Licenses Technology for Thermal Cyclers to Bulldog Bio
Date:9/7/2011

HAMBURG, Germany, September 7, 2011 /PRNewswire/ --

Eppendorf AG has licensed patents covering gradient technology for thermal cyclers to Bulldog Bio Inc. for use in their thermal cyclers, including US patent Nos. 6,767,512 and 7,074,367. Eppendorf utilizes the technology in its Eppendorf Mastercycler® pro gradient, Mastercycler gradient and Mastercycler ep realplex models.

Eppendorf AG, based in Hamburg, Germany, develops, produces and distributes instruments and consumables for the Life Science research industry. Additional information is available at:  http://www.eppendorf.com.

Contact:
Sven Bülow, Ph.D.
Executive Vice President
Corporate Development
Eppendorf AG
Barkhausenweg 1
22339 Hamburg
Germany
Phone: +49-40-53801-500
Fax: +49-40-53801-757
e-mail: buelow.s@eppendorf.de


'/>"/>
SOURCE Eppendorf AG
Copyright©2010 PR Newswire.
All rights reserved

Page: 1

Related biology technology :

1. Eppendorf Successfully Initiates Import ban Against Nanosphere, Inc. for the Countries of the European Union
2. Amsterdam Molecular Therapeutics Licenses Additional Novel Gene Therapy Vectors from National Institutes of Health
3. EdeniQ Licenses Yeast Technology from USDA
4. SynapDx Corporation Licenses Autism Diagnostic Discoveries From Childrens Hospital Boston
5. Cellular Dynamics Licenses Technology From ViaCyte
6. China PharmaHub In-Licenses Universal Donor Red Blood Cells Technology Exclusively From University of California, San Diego
7. Stemline Therapeutics Licenses Phase I/II Brain Cancer Vaccine - Shows Promise in Clinical Trial Conducted at University of Pittsburgh
8. Cellectis Plant Sciences Licenses Plant Transformation Technology for Corn and Rice
9. Cellectis Plant Sciences Licenses Plant Transformation Technology From Midwest Oilseeds
10. Auxogyn Licenses Non-invasive Embryo Assessment Technology From Stanford University
11. NEURO-BIOTECH DISCLOSES ITS LIST OF LICENSES
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/23/2016)... /PRNewswire/ - FACIT has announced the creation of ... company, Propellon Therapeutics Inc. ("Propellon" or "the Company"), ... portfolio of first-in-class WDR5 inhibitors for the treatment ... represent an exciting class of therapies, possessing the ... cancer patients. Substantial advances have been achieved with ...
(Date:6/23/2016)... MONICA, Calif. , June 23, 2016  The Prostate Cancer Foundation ... pioneer increasingly precise treatments and faster cures for prostate cancer. Members of the ... institutions across 15 countries. Read More About the Class ... ... ...
(Date:6/23/2016)... ... June 23, 2016 , ... STACS DNA Inc., the sample ... the Arkansas State Crime Laboratory, has joined STACS DNA as a Field Application Specialist. ... said Jocelyn Tremblay, President and COO of STACS DNA. “In further expanding our capacity ...
(Date:6/23/2016)... 2016 Andrew D ... http://doi.org/10.17925/OHR.2016.12.01.22 Published recently in ... from touchONCOLOGY, Andrew D Zelenetz , discusses ... care is placing an increasing burden on healthcare ... therapies. With the patents on many biologics expiring, ...
Breaking Biology Technology:
(Date:4/28/2016)... 28, 2016 First quarter 2016:   ... compared with the first quarter of 2015 The gross ... M (loss: 18.8) and the operating margin was 40% (-13) ... Cash flow from operations was SEK 249.9 M (21.2) , ... is unchanged, SEK 7,000-8,500 M. The operating margin for ...
(Date:4/15/2016)... April 15, 2016  A new partnership announced ... accurate underwriting decisions in a fraction of the ... priced and high-value life insurance policies to consumers ... With Force Diagnostics, rapid testing (A1C, Cotinine ... readings (blood pressure, weight, pulse, BMI, and activity ...
(Date:3/31/2016)...   LegacyXChange, Inc. ... LegacyXChange is excited to release its first ... be launched online site for trading 100% guaranteed authentic ... also provide potential shareholders a sense of the value ... industry that is notorious for fraud. The video is ...
Breaking Biology News(10 mins):